Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Tuberculosis

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 63 articles: HTML format

Single Articles

May 2022
1. KUA KP, Chongmelaxme B, Lee S
   Association between cytomegalovirus infection and tuberculosis disease: A systematic review and meta-analysis of epidemiological studies.
   J Infect Dis. 2022 May 4. pii: 6580085. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. WALKER NF, Karim F, Moosa M, Moodley S, et al
   Elevated Plasma Matrix Metalloproteinase-8 associates with Sputum Culture Positivity in Pulmonary Tuberculosis.
   J Infect Dis. 2022 May 1. pii: 6576469. doi: 10.1093.
   PubMed     Abstract available
   
   
   March 2022
3. NGO MD, Bartlett S, Bielefeldt-Ohmann H, Foo CX, et al
   A blunted GPR183/oxysterol axis during dysglycemia results in delayed recruitment of macrophages to the lung during M. tuberculosis infection.
   J Infect Dis. 2022 Mar 18. pii: 6550675. doi: 10.1093.
   PubMed     Abstract available
   
   
   February 2022
4. TEPEKULE B, Kusejko K, Zeeb M, Tarr PE, et al
   Impact of Latent Tuberculosis Infection on the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study.
   J Infect Dis. 2022 Feb 16. pii: 6529706. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. JIA P, Zhang Y, Xu J, Zhu M, et al
   IMB-BZ as an Inhibitor Targeting ESX-1 Secretion System to Control Mycobacterial Infection.
   J Infect Dis. 2022;225:608-616.
   PubMed     Abstract available
   
   
   
6. AGARWAL S, Tiwari P, Deep A, Kidwai S, et al
   Corrigendum to: System-Wide Analysis Unravels the Differential Regulation and In Vivo Essentiality of Virulence-Associated Proteins B and C Toxin-Antitoxin Systems of Mycobacterium tuberculosis.
   J Infect Dis. 2022 Feb 11. pii: 6526953. doi: 10.1093.
   PubMed    
   
   
   January 2022
7. ZURCHER K, Riou J, Morrow C, Ballif M, et al
   Estimating Tuberculosis Transmission Risks in a Primary Care Clinic in South Africa: Modeling of Environmental and Clinical Data.
   J Infect Dis. 2022 Jan 18. pii: 6510424. doi: 10.1093.
   PubMed     Abstract available
   
   
   December 2021
8. SAHA A, Escudero J, Layouni T, Richardson B, et al
   Mycobacterium tuberculosis-specific T cell responses are impaired during late pregnancy with elevated biomarkers of tuberculosis risk postpartum.
   J Infect Dis. 2021 Dec 20. pii: 6470923. doi: 10.1093.
   PubMed     Abstract available
   
   
   
9. GERIC C, Saroufim M, Landsman D, Richard J, et al
   Impact of Covid-19 on Tuberculosis Prevention and Treatment in Canada: a multicentre analysis of 10,833 patients.
   J Infect Dis. 2021 Dec 17. pii: 6469005. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. POERIO N, Caccamo N, La Manna MP, Olimpieri T, et al
    Phosphatidylserine liposomes reduce inflammatory response, mycobacterial viability and HIV replication in coinfected human macrophages.
    J Infect Dis. 2021 Dec 15. pii: 6463308. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2021
11. HLAKA L, Ozturk M, Chia JE, Jones SS, et al
    IL-4i1 regulates immune protection during Mycobacterium tuberculosis infection.
    J Infect Dis. 2021 Nov 5. pii: 6421699. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2021
12. ARRIAGA MB, Araujo-Pereira M, Barreto-Duarte B, Nogueira B, et al
    The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multi-center Prospective Cohort Study.
    J Infect Dis. 2021 Oct 15. pii: 6398049. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2021
13. LONG R, Lau A, Egedahl ML, Paulsen C, et al
    Local Transmission Plays No Important Role in the Occurrence of Multidrug-Resistant Tuberculosis in Immigrants to Canada: An In-depth Epidemiologic Analysis.
    J Infect Dis. 2021;224:1029-1038.
    PubMed     Abstract available
    
    
    
14. PIETERMAN ED, Keutzer L, van der Meijden A, van den Berg S, et al
    Superior Efficacy of a Bedaquiline, Delamanid, and Linezolid Combination Regimen in a Mouse Tuberculosis Model.
    J Infect Dis. 2021;224:1039-1047.
    PubMed     Abstract available
    
    
    
15. CHEN Y, Ji L, Liu Q, Li J, et al
    Lesion Heterogeneity and Long-Term Heteroresistance in Multidrug-Resistant Tuberculosis.
    J Infect Dis. 2021;224:889-893.
    PubMed     Abstract available
    
    
    July 2021
16. HALLIDAY A, Masonou T, Tolosa-Wright MR, Guo Y, et al
    Defining the Role of Cellular Immune Signatures in Diagnostic Evaluation of Suspected Tuberculosis.
    J Infect Dis. 2021 Jul 31. pii: 6332782. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2021
17. ARRIAGA MB, Rocha MS, Nogueira B, Nascimento V, et al
    The Effect of Diabetes and Prediabetes on Mycobacterium tuberculosis Transmission to Close Contacts.
    J Infect Dis. 2021 May 19. pii: 6278117. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. PARVEEN S, Lun S, Urbanowski ME, Cardin M, et al
    Effective host-directed therapy for tuberculosis by targeted depletion of myeloid-derived suppressor cells and related cells using a diphtheria toxin-based fusion protein.
    J Infect Dis. 2021 May 6. pii: 6270734. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2021
19. DUFFY FJ, Olson GS, Gold ES, Jahn A, et al
    A contained Mycobacterium tuberculosis mouse infection model predicts active disease and containment in humans.
    J Infect Dis. 2021 Mar 10. pii: 6167837. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2021
20. MUDDE SE, Alsoud RA, van der Meijden A, Upton AM, et al
    Predictive modeling to study the treatment-shortening potential of novel tuberculosis drug regimens, towards bundling of preclinical data.
    J Infect Dis. 2021 Feb 19. pii: 6145049. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. RAO MUVVA J, Ahmed S, Rekha RS, Kalsum S, et al
    Immunomodulatory agents combat multidrug-resistant tuberculosis by improving antimicrobial immunity.
    J Infect Dis. 2021 Feb 19. pii: 6145048. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. DUBEY N, Khan MZ, Kumar S, Sharma A, et al
    Mycobacterium tuberculosis PPiA interacts with host integrin receptor to exacerbate disease progression.
    J Infect Dis. 2021 Feb 13. pii: 6134355. doi: 10.1093.
    PubMed     Abstract available
    
    
    
23. LAI CC, Tehrani B, Yungtum G, Hsu WT, et al
    Association between the use of statins and risk of tuberculosis: a real-world analysis.
    J Infect Dis. 2021 Feb 8. pii: 6131374. doi: 10.1093.
    PubMed    
    
    
    
24. BEHR MA, Divangahi M, Schurr E
    Lessons From Bacille Calmette-Guerin for SARS-CoV-2 Vaccine Candidates.
    J Infect Dis. 2021;223:189-191.
    PubMed     Abstract available
    
    
    January 2021
25. STEIN CM, Benchek P, Bartlett J, Igo RP, et al
    Methylome-wide analysis reveals epigenetic marks associated with resistance to tuberculosis in HIV-infected individuals from East Africa.
    J Infect Dis. 2021 Jan 5. pii: 6064776. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2020
26. BARBOSA BOMFIM CC, Pinheiro Amaral E, Santiago-Carvalho I, Almeida Santos G, et al
    Granulocytic Myeloid-Derived Suppressor Cells Aggravate Tuberculosis Caused by Hypervirulent Mycobacteria.
    J Infect Dis. 2020 Nov 18. pii: 5989003. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2020
27. DONOVAN J, Tram TTB, Phu NH, Hiep NTT, et al
    The influence of Strongyloides stercoralis co-infection on the presentation, pathogenesis and outcome of tuberculous meningitis.
    J Infect Dis. 2020 Oct 26. pii: 5940016. doi: 10.1093.
    PubMed     Abstract available
    
    
    
28. HJORT K, Juren P, Toro JC, Hoffner S, et al
    Dynamics of extensive drug resistance evolution of Mycobacterium tuberculosis in a single patient during 9 years of disease and treatment.
    J Infect Dis. 2020 Oct 12. pii: 5921146. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. AGARWAL S, Tiwari P, Deep A, Kidwai S, et al
    Corrigendum to: System-Wide Analysis Unravels the Differential Regulation and In Vivo Essentiality of Virulence-Associated Proteins B and C Toxin-Antitoxin Systems of Mycobacterium tuberculosis.
    J Infect Dis. 2020 Oct 7. pii: 5918919. doi: 10.1093.
    PubMed    
    
    
    September 2020
30. LOONEY MM, Lu Y, Karakousis PC, Halushka MK, et al
    Mycobacterium tuberculosis infection drives mitochondria-biased dysregulation of host tRNA-derived fragments.
    J Infect Dis. 2020 Sep 22. pii: 5909842. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. ZHANG S, Li G, Bi J, Guo Q, et al
    Functional nucleotide polymorphisms up-regulating transforming growth factor beta1 expression are associated with increased tuberculosis susceptibility.
    J Infect Dis. 2020 Sep 16. pii: 5906652. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2020
32. EISENHUT M
    The influence of cigarette smoke on results of hematological and immunological investigations in patients exposed to Mycobacterium tuberculosis.
    J Infect Dis. 2020 Jul 29. pii: 5877958. doi: 10.1093.
    PubMed    
    
    
    
33. CAMPBELL N, Verrall AJ, Donkor S, Sutherland JS, et al
    BCG protection against Mycobacterium tuberculosis infection by level of exposure in The Gambia.
    J Infect Dis. 2020 Jul 8. pii: 5868549. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2020
34. DUTTA NK, Karakousis PC
    Reply to Hu et al: Could there be detrimental effects of statin adjunctive TB therapy on immune responses?
    J Infect Dis. 2020;222:336-337.
    PubMed    
    
    
    May 2020
35. OSAWA T, Watanabe M, Morimoto K, Okumura M, et al
    Serum procalcitonin levels predict mortality risk in patients with pulmonary tuberculosis: a single-center prospective observational study.
    J Infect Dis. 2020 May 23. pii: 5843442. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. HE X, Eddy JJ, Jacobson KR, Henderson AJ, et al
    Enhanced HIV-1 Replication in CD4+ T Cells Derived from Individuals with Latent Mycobacterium tuberculosis Infection.
    J Infect Dis. 2020 May 16. pii: 5838261. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2020
37. KUMAR NP, Kathamuthu GR, Moideen K, Banurekha VV, et al
    Strongyloides stercoralis coinfection is associated with greater disease severity, higher bacterial burden and elevated plasma matrix metalloproteinases in pulmonary tuberculosis.
    J Infect Dis. 2020 Apr 20. pii: 5822617. doi: 10.1093.
    PubMed     Abstract available
    
    
    
38. SULIMAN S, Gela A, Mendelsohn SC, Iwany SK, et al
    Peripheral blood mucosal-associated invariant T (MAIT) cells in tuberculosis patients and healthy Mycobacterium tuberculosis-exposed controls.
    J Infect Dis. 2020 Apr 8. pii: 5817894. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2020
39. KAUSHAL D
    The Comeback Kid: BCG.
    J Infect Dis. 2020;221:1031-1032.
    PubMed    
    
    
    February 2020
40. LU LL, Das J, Grace PS, Fortune SM, et al
    Antibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosis.
    J Infect Dis. 2020 Feb 15. pii: 5736363. doi: 10.1093.
    PubMed     Abstract available
    
    
    
41. EISINGER RW, Embry AC, Read SW, Fauci AS, et al
    2019: A Banner Year for Tuberculosis Research.
    J Infect Dis. 2020 Feb 11. pii: 5719366. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2020
42. CLICK ES, Kurbatova E, Alexander H, Dalton TL, et al
    Isoniazid- and Rifampin-Resistance Mutations Associated with Resistance to Second-line Drugs and with Sputum Culture Conversion.
    J Infect Dis. 2020 Jan 31. pii: 5718252. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. BIGELOW KM, Deitchman AN, Li SY, Barnes-Boyle K, et al
    Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of Tuberculosis.
    J Infect Dis. 2020 Jan 29. pii: 5716916. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. SONG Y, Hussain T, Wang J, Liao Y, et al
    Mitochondrial Transcription Factor A Regulates Mycobacterium bovis-Induced IFN-beta Production by Modulating Mitochondrial DNA Replication in Macrophages.
    J Infect Dis. 2020;221:438-448.
    PubMed     Abstract available
    
    
    December 2019
45. HU Z, Lowrie DB, Fan XY
    Statins as adjunctive therapy against tuberculosisthe balance between statin-induced anti-TB effect and trained immunity suppression.
    J Infect Dis. 2019 Dec 24. pii: 5686380. doi: 10.1093.
    PubMed    
    
    
    
46. ALBERTO CHORENO-PARRA J, Bobba S, Rangel-Moreno J, Ahmed M, et al
    Mycobacterium tuberculosis HN878 infection induces human-like B cell follicles in mice.
    J Infect Dis. 2019 Dec 13. pii: 5674951. doi: 10.1093.
    PubMed     Abstract available
    
    
    
47. TORNHEIM JA, Madugundu AK, Paradkar M, Fukutani KF, et al
    Transcriptomic Profiles of Confirmed Pediatric Tuberculosis Patients and Household Contacts Identifies Active Tuberculosis, Infection, and Treatment Response among Indian Children.
    J Infect Dis. 2019 Dec 4. pii: 5651247. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2019
48. PEETLUK LS, Rebeiro PF, Cordeiro-Santos M, Kritski A, et al
    Lack of weight gain during the first two months of treatment and HIV independently predict unsuccessful treatment outcomes in tuberculosis.
    J Infect Dis. 2019 Nov 14. pii: 5625394. doi: 10.1093.
    PubMed     Abstract available
    
    
    
49. STOCKDALE L, Nash S, Farmer R, Raynes J, et al
    Cytomegalovirus antibody responses associated with increased risk of TB disease in Ugandan adults.
    J Infect Dis. 2019 Nov 5. pii: 5613526. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2019
50. SIMMONS JD, Peterson GJ, Campo M, Lohmiller J, et al
    Nicotinamide limits replication of Mycobacterium tuberculosis and BCG within macrophages.
    J Infect Dis. 2019 Oct 31. pii: 5610259. doi: 10.1093.
    PubMed     Abstract available
    
    
    
51. STEIN CM, Mayanja-Kizza H, Hawn TR, Boom WH, et al
    Importance of study design and phenotype definition in ongoing studies of resistance to latent M. tuberculosis infection.
    J Infect Dis. 2019 Oct 30. pii: 5609437. doi: 10.1093.
    PubMed    
    
    
    
52. SAKAMURI RM, Singh KK, Ryndak MB, Laal S, et al
    Evolution of antibodies to epitopes of PE_PGRS51 in the spectrum of active pulmonary tuberculosis.
    J Infect Dis. 2019 Oct 23. pii: 5602685. doi: 10.1093.
    PubMed     Abstract available
    
    
    
53. DUTTA NK, Bruiners N, Zimmerman MD, Tan S, et al
    Adjunctive host-directed therapy with statins improves tuberculosis-related outcomes in mice.
    J Infect Dis. 2019 Oct 12. pii: 5586531. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. NATHAVITHARANA RR, Yoon C, Macpherson P, Dowdy DW, et al
    Guidance for Studies Evaluating the Accuracy of Tuberculosis Triage Tests.
    J Infect Dis. 2019;220.
    PubMed     Abstract available
    
    
    
55. GEORGHIOU SB, Schumacher SG, Rodwell TC, Colman RE, et al
    Guidance for Studies Evaluating the Accuracy of Rapid Tuberculosis Drug-Susceptibility Tests.
    J Infect Dis. 2019;220.
    PubMed     Abstract available
    
    
    
56. DRAIN PK, Gardiner J, Hannah H, Broger T, et al
    Guidance for Studies Evaluating the Accuracy of Biomarker-Based Nonsputum Tests to Diagnose Tuberculosis.
    J Infect Dis. 2019;220.
    PubMed     Abstract available
    
    
    
57. SCHUMACHER SG, Wells WA, Nicol MP, Steingart KR, et al
    Guidance for Studies Evaluating the Accuracy of Sputum-Based Tests to Diagnose Tuberculosis.
    J Infect Dis. 2019;220.
    PubMed     Abstract available
    
    
    
58. DENKINGER CM, Schumacher SG, Gilpin C, Korobitsyn A, et al
    Guidance for the Evaluation of Tuberculosis Diagnostics That Meet the World Health Organization (WHO) Target Product Profiles: An Introduction to WHO Process and Study Design Principles.
    J Infect Dis. 2019;220.
    PubMed     Abstract available
    
    
    July 2019
59. HORTLE E, Johnson KE, Johansen MD, Nguyen T, et al
    Thrombocyte Inhibition Restores Protective Immunity to Mycobacterial Infection in Zebrafish.
    J Infect Dis. 2019;220:524-534.
    PubMed     Abstract available
    
    
    June 2019
60. AFKHAMI S, Lai R, D'Agostino MR, Vaseghi-Shanjani M, et al
    Single-dose mucosal immunotherapy with chimpanzee adenovirus-based vaccine accelerates TB disease control and limits its rebound following antibiotic cessation.
    J Infect Dis. 2019 Jun 13. pii: 5519039. doi: 10.1093.
    PubMed     Abstract available
    
    
    
61. HU Z, Lu SH, Lowrie DB, Fan XY, et al
    Reply to Tonby et al.
    J Infect Dis. 2019;220:176-178.
    PubMed    
    
    
    May 2019
62. KROEZE S, Wit FW, Rossouw TM, Steel HC, et al
    Plasma biomarkers of HIV-related systemic inflammation and immune activation in sub-Saharan Africa before and during suppressive antiretroviral therapy.
    J Infect Dis. 2019 May 14. pii: 5489039. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2018
63. THUONG NTT, Vinh DN, Hai HT, Thu DDA, et al
    Pre-treatment cerebrospinal fluid bacterial load correlates with inflammatory response and predicts neurological events during tuberculous meningitis treatment.
    J Infect Dis. 2018 Oct 9. pii: 5123684. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: